![Marc Cluzel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Cluzel
Direttore/Membro del Consiglio presso
Moleac Pte Ltd.
Profilo
Marc Cluzel is the founder of C&F Consulting, which was founded in 2011.
He is currently an Independent Director at Moleac Pte Ltd. and a Director at Griffon Pharmaceuticals, Inc. Dr. Cluzel previously served as the Chairman & Chief Executive Officer of Sanofi-Aventis Recherche et Développement SA from 2002 to 2011.
He also held the position of Chairman-Supervisory Board at MorphoSys AG from 2018 to 2024.
Additionally, Dr. Cluzel was the Executive Vice President-Research & Development at Sanofi from 1991 to 2010 and the Executive Vice President-Product Development at HUYA Bioscience International LLC from 2011 to 2012.
He obtained a doctorate degree from Université de Montpellier in 1990 and another doctorate degree in 1985.
Posizioni attive di Marc Cluzel
| Società | Posizione | Inizio |
|---|---|---|
Moleac Pte Ltd.
 Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes biopharmaceutical products | Direttore/Membro del Consiglio | - |
Griffon Pharmaceuticals, Inc.
 Griffon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Marc Cluzel
| Società | Posizione | Fine |
|---|---|---|
| MORPHOSYS AG | Presidente | 06/06/2024 |
Huyabio International LLC
 Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | 02/01/2012 |
Sanofi-Aventis Recherche et Développement SA
 Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development of physical & natural sciences, vaccines and medicines | Amministratore Delegato | 01/01/2011 |
| SANOFI | Direttore Tecnico/Scientifico/R&S | 01/01/2010 |
C&F Consulting | Fondatore | - |
Formazione di Marc Cluzel
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Université de Montpellier
 Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Recherche et Développement SA
Sanofi-Aventis Recherche et Développement SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development of physical & natural sciences, vaccines and medicines | Commercial Services |
C&F Consulting | |
Griffon Pharmaceuticals, Inc.
Griffon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Health Technology |
